Clinical Trials
6 trialsNCT02009449 2024-11-15
IVY
Eli Lilly and Company
Phase 1 Completed
NCT00006023 2019-06-26
Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Swiss Cancer Institute
Phase 2 Completed
NCT00003704 2016-07-06
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Alliance for Clinical Trials in Oncology
Phase 1 Completed
NCT00124566 2016-01-18
Study of Irofulven in Patients With Hormone-refractory Prostate Cancer
Eisai Inc.
Phase 2 Completed
NCT00151047 2015-01-21
Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00258284 2014-03-06
Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Completed